SCHEMBL4356333

SCHEMBL4356333

CCN1CCCC(NC(=O)c2ccccc2)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.58
ACSS2 Q9NR19 2/20 0.57
CHRM1 P11229 1/20 0.56
CCR2 P41597 1/20 0.55
CARM1 Q86X55 1/20 0.55
PRMT6 Q96LA8 1/20 0.55
GAA P10253 1/20 0.55
DRD2 P14416 3/20 0.54
DRD4 P21917 3/20 0.54
CTSL P07711 1/20 0.53
CTSB P07858 1/20 0.53
CTSK P43235 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
GABRA5 P31644 1/20 0.53
OPRM1 P35372 1/20 0.53
OPRK1 P41145 1/20 0.53
HPGD P15428 1/20 0.52
USP30 Q70CQ3 1/20 0.50
ADRA1D P25100 1/20 0.50
ADRA1A P35348 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13211820 0.88 NPC1 (0.61) PKMACSS2CCR2GAANPSR1
SCHEMBL11245499 0.87 PKM (0.54) PKMACSS2GAADRD2DRD4
SCHEMBL13162925 0.83 MEN1 (0.71) CHRM1GAA
SCHEMBL18286474 0.83 CARM1 (0.72) CARM1PRMT6DRD4NPSR1ADRA1D
SCHEMBL4356360 0.82 CTSL (0.57) CHRM1CARM1PRMT6CTSLCTSB
SCHEMBL10210847 0.82 CTSL (0.57) CHRM1CARM1PRMT6CTSLCTSB
SCHEMBL12437666 0.80 HRH3 (0.58) PKMACSS2OPRM1
SCHEMBL25366529 0.79 GAA (0.51) ACSS2GAAGABRA5
SCHEMBL967298 0.79 GAA (0.51) ACSS2GAAGABRA5
SCHEMBL15031312 0.79 PKM (0.47) PKMACSS2GAAGABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2056829-A2 USING PI3K AND MEK MODULATORS IN TREATMENTS OF CANCER Exelixis, Inc. (US) 2009-05-13 EP claimed
WO-2008021389-A2 USING PI3K AND MEK MODULATORS IN TREATMENTS OF CANCER EXELIXIS, INC. (US) 2008-02-21 WO claimed